Scientists have found that drugs called PD-1 inhibitors can make the blood-brain barrier more permeable, a process mediated by the DKK1 protein. This finding explains why some patients develop brain metastases during treatment and suggests new ways to improve drug delivery to the brain
Source:
www.thehindu.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
